SR

Swetha Rallapalli

Active Director Director DIN 02970345
DIN 02970345 First appointment Mar 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 8 active board seats
Total affiliations 8 Since Mar 2010
Shareholding value •••• Premium profile

About Swetha Rallapalli

Data last updated:

Swetha Rallapalli is a Director at Siflon Pharma Private Limited (since 2022), Managing Director at Siflon Drugs And Pharmaceuticals Private Limited (since 2014) and Director at Siflon Polymers Private Limited (since 2014), and holds 5 more current directorships. The companies operate in Pharma, Manufacturing and Agriculture. The 8 current companies with reported revenue have a combined latest revenue of ₹236 Cr; the largest is Siflon Pharma Private Limited at ₹149 Cr (FY 2025).

DIN 02970345
Primary Designation Director
Industry Pharma
First Appointment 19 Mar 2010
Oldest Company Age 23 yrs
Largest company Siflon Pharma Private Limited · ₹149 Cr (FY 2025)
Combined revenue ₹236 Cr across 8 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Siflon Pharma Private Limited U24200AP2022PTC121807
Director27 May 20222022₹149 Cr (FY 2025)Active
Managing Director28 Jul 20142006₹40.38 Cr (FY 2025)Active
Siflon Polymers Private Limited U25206AP2003PTC040882
Director14 Feb 20142003₹26.57 Cr (FY 2025)Active
Director10 Feb 20162016₹12.84 Cr (FY 2023)Active
Siflon Drugs Private Limited U24232TG2010PTC067606
Director19 Mar 20102010₹6.38 Cr (FY 2025)Active
Siflon Engineering Private Limited U29297TG2014PTC096293
Managing Director10 Nov 20142014₹49.7 Lakh (FY 2022)Active
Manoj Animal Health Private Limited U24299TG2019PTC136095
Director15 Oct 20192019₹3.1 Lakh (FY 2025)Active
Siflon Green Energy Private Limited U40102AP2014PTC095412
Director30 Sep 20142014₹8,130 (FY 2022)Active

Directorship timeline

Open interactive timeline →
Siflon Pharma Private Limited
Siflon Drugs Private Limited
Siflon Drugs And Pharmaceuticals Private Limited
Manoj Animal Health Private Limited
Premium access

Shareholding and investment profile for Swetha Rallapalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swetha Rallapalli

Swetha Rallapalli currently holds 8 directorships: Siflon Pharma Private Limited (Director, since 27 May 2022, revenue ₹149 Cr (FY 2025)); Siflon Drugs And Pharmaceuticals Private Limited (Managing Director, since 28 Jul 2014, revenue ₹40.38 Cr (FY 2025)); Siflon Polymers Private Limited (Director, since 14 Feb 2014, revenue ₹26.57 Cr (FY 2025)); Siflon Drip And Sprinklers Private Limited (Director, since 10 Feb 2016, revenue ₹12.84 Cr (FY 2023)); Siflon Drugs Private Limited (Director, since 19 Mar 2010, revenue ₹6.38 Cr (FY 2025)); and 3 more.

Swetha Rallapalli was first appointed on 19 Mar 2010 as Director at Siflon Drugs Private Limited. The most recent appointment on record is 27 May 2022 at Siflon Pharma Private Limited.

The 8 current companies of Swetha Rallapalli that report revenue have a combined latest revenue of ₹236 Cr: Siflon Pharma Private Limited ₹149 Cr (FY 2025); Siflon Drugs And Pharmaceuticals Private Limited ₹40.38 Cr (FY 2025); Siflon Polymers Private Limited ₹26.57 Cr (FY 2025); Siflon Drip And Sprinklers Private Limited ₹12.84 Cr (FY 2023); Siflon Drugs Private Limited ₹6.38 Cr (FY 2025); and 3 more.

The current boards of Swetha Rallapalli's companies include Ananthaiah Rallapalli (Siflon Pharma Private Limited), Parvathi Rallapalli (Siflon Pharma Private Limited), Bommineni Ashok Chakravarthi (Siflon Polymers Private Limited), Chowdappa Chowdary Vunnam (Siflon Green Energy Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available